Steven Seyedin, MD

University of California Irvine

Orange, CA

Steven Seyedin is a 1st year attending at the University of California, Irvine who plans on focusing on translational research for gastrointestinal and genitourinary cancers. During his residency at the University of Iowa Hospital and Clinics, he conducted preclinical research investigating the combination of PARP inhibition and radiation towards enhancing the effect of anti-PD-1 therapy in a murine colorectal cancer model.

Disclosures:

Employment: none
Compensation: none
Ownership: none
Leadership: none

Presentations

Sep 30

3335 - The Impact of ARBs and ACE Inhibitors during Chemoradiotherapy on Outcomes for Muscle Invasive Bladder Cancer

Hall F

12:45pm - 02:00pm PT